New survey shows financial pain for employers and employees with few good options to manage the trend
CHICAGO-Healthcare costs for employer-sponsored health plans are expected to increase by more than 10% in 2010, according to a survey of more than 60 health insurance companies.
Aon Consulting, surveyed plans serving more than 100 million insured individuals.
"While we're seeing a slight decrease in the trend rates, it's still at double digits, and this year, it's compounded by a struggling economy, layoffs and salary freezes or reductions," says Tom Lerche, healthcare practice leader for Aon Consulting.
THREE WAYS TO SHAPE PLANS
Because the spiraling cost trend for the next 12 months is expected to increase 10% or more, plan sponsors are focused on tactics and strategies to reduce medical trend to mid- to low-single digits.
"Given the financial pain on both companies and employees from the recession, employers are re-examining changes in health plan options, plans design, and clinical solutions which may have been rejected in 2008," Lerche says. "In particular, employers are conducting audits to saving money in the short run and designing and implementing wellness strategies for long-term impact."
According to Lerche, there are three ways most plan sponsors may shape their plan offerings for 2010:
Additionally, prescription drug cost increases are expected. The Aon survey projects drug costs will increase 9.3% in 2010, slightly lower than the 9.4% trend rate one year ago.
In this second part of a two-part podcast episode, Managed Healthcare Executive's Managing Editor Peter Wehrwein spoke with CeCi Connolly and Margaret "Meg" Murray about Medicare Advantage utilization and challenges, highlighting proposed CMS payment cuts and prior authorization issues.
Listen
2024 Emerging Leaders in Healthcare — Submit For a Chance to Be Featured in MHE's August Issue
March 26th 2024MHE Editors are seeking diverse healthcare professionals from different backgrounds and healthcare sectors, with individual interests. Eligible candidates are early or mid-career leaders with less than 10 years of experience. Award winners will enjoy complimentary passes to the PBMI Annual National Meeting in Orlando, Florida, from Sept. 4-6. Additional perks include a feature in our August issue, a subscription to MHE and more!
Read More
In this first part of a two-part podcast episode, Managed Healthcare Executive's Managing Editor Peter Wehrwein kicks off our new podcast series "DC Roundtable," with guests Margaret "Meg" Murray, CEO of the Association of Community Affiliated Plans, and member of MHE's Editorial Advisory Board, and CeCi Connolly, president and CEO of the Alliance of Community Health Plans, for a discussion on healthcare policy issues.
Listen
What States are Doing to Regulate Pharmacy Benefit Managers
March 26th 2024In a poster presented at the 2024 American Pharmacists Association Annual Meeting and Exposition, researchers found that state-level PBM reform focused on more transparent drug pricing, better patient access to prescription drugs, and more stringent auditing and reporting requirements.
Read More
FDA Approves Combination Therapy for Pulmonary Arterial Hypertension
March 26th 2024J&J’s Opsynvi is single-tablet combination of macitentan, an endothelin receptor antagonist, and tadalafil, a PDE5 inhibitor. It will be priced on parity with Opsumit, which is also a J&J product to treat patients with PAH.
Read More